University of Michigan Rogel Cancer Center is about to start a clinical trial with partnership with the cancer support community ®Chatbot program cancer treatment support
Photo by Markus Winkler
University of Michigan Rogel Cancer Center is commencing recruitment for the clinical trial. This is Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program Cancer Treatment Support in Partnership With the Cancer Support Community.
This study is designed to study the feasibility and acceptability of the Open to Options (O2O) Chatbot prototype. The O2O program is an existing patient support program with content currently delivered via in-person counseling with a trained mental health professional or via an existing web-based program (Let's Talk Treatment Options).The Chatbot is an automated, menu-based agent being developed in this study to extend the reach and accessibility of the O2O program via the Chatbot's "virtual coaching".
This is a pilot study to assess feasibility and acceptability, and to gather preliminary data on how patients with a new diagnosis of cancer appraise being prepared for their upcoming visit with a cancer specialist. Participants will be randomized to take a survey either before or after their Chatbot interaction. The surveys collect participants' self-appraisal regarding preparedness for their upcoming appointment with a cancer physician, cancer distress and cancer anxiety. The study will examine whether patients who take the survey after viewing the Chatbot feel more prepared for their upcoming appointment than those who take the survey before the Chatbot interaction.
A new clinical trial is recruiting patients in the following locations: United States.
The trial officially began on the November 2020 and is planned to complete on May 2021.
The population that can be enrolled into this study includes:
- Patients with a new cancer diagnosis (for the purposes of this pilot, recruitment is anticipated to take place in colon, breast, and melanoma oncology clinics).
- Appointment with a Rogel Cancer Center cancer clinician within the next 3 weeks.
- Patient must have a way to access the internet (includes mobile phone).
Cancer Support Community is the collaborator in this clinical trial.
The link to the complete study profile: https://ichgcp.net/clinical-trials-registry/NCT04616651.
